A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

Genetic alterations in PI3K (phosphoinositide 3-kinase) signalling are common in cancer and include deletions in PTEN (phosphatase and tensin homologue deleted on chromosome 10), amplifications of PIK3CA and mutations in two distinct regions of the PIK3CA gene. This suggests drugs targeting PI3K, an...

Full description

Bibliographic Details
Main Authors: Jamieson, Stephen, Flanagan, Jack U., Kolekar, Sharada, Buchanan, Christina, Kendall, Jackie D., Lee, Woo-Jeong, Rewcastle, Gordon W., Denny, William A., Singh, Ripudaman, Dickson, James, Baguley, Bruce C., Shepherd, Peter R.
Format: Online
Language:English
Published: Portland Press Ltd. 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174055/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174055/

Similar Items